A growing body of evidence suggests that the plasminogen activator (PA) system is crucially involved in reproductive physiology in both sexes. Certain factors of the PA system have been found to be present in organs of the male reproductive tract in various species, and the presence of several of the factors was recently demonstrated in monkey testis. The present morphological study was therefore designed to investigate the occurrence and distribution of the tissue and urokinase plasminogen activators (t-PA and u-PA), the u-PA receptor (u-PAR) and the plasminogen activator inhibitors (PAI-1 and PAI-2) in normal human testis. Intraoperative specimens from seven patients undergoing orchidectomy or testicular biopsy were studied using in-situ hybridization (ISH) and immunohistochemistry (IHC). All five factors studied could be detected with both the ISH and IHC procedures. The ISH signals were localized to sites in the testicular tubules in a stage-specific manner. There was good correlation between results obtained with the two methods, though in IHC the tubules were stained more uniformly. The findings provide support for the involvement of the PA system in human male reproductive physiology.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/molehr/5.10.934 | DOI Listing |
Med Klin Intensivmed Notfmed
January 2025
Neurologische Klinik, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Deutschland.
Intravenous thrombolysis (IVT) and endovascular therapy (EVT) are the cornerstones of acute ischemic stroke treatment. While IVT has been an integral part of acute therapy since the mid-1990s, EVT has evolved as one of the most effective treatments in medicine over the past decade. Traditionally, systemic thrombolysis has been performed with alteplase (rtPA).
View Article and Find Full Text PDFProg Neuropsychopharmacol Biol Psychiatry
January 2025
Department of Psychiatry, University Medical Center Groningen, Groningen, the Netherlands.
Psilocybin represents a novel therapeutic approach for individuals with major depressive disorder (MDD) who do not respond to conventional antidepressant treatment. Investigating the influence of psilocybin on the pathophysiological processes involved in MDD could enhance our neurobiological understanding of the presumed antidepressant action mechanism. This systematic review aims to summarize the results of human studies investigating changes in blood-based biomarkers of MDD to guide future research on potentially relevant analytes that could be monitored in clinical trials.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Division of clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Stockholm, Sweden.
Background: The Cardiovascular risk factors, aging, and dementia (CAIDE) risk score is a validated tool estimating dementia risk. We investigated the association of CAIDE score with 12 markers of glucose and lipid metabolism, in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) participants.
Methods: The FINGER trial had 1260 participants, aged 60-77 years, with a CAIDE score ≥6, without substantial cognitive impairment.
Alzheimers Dement
December 2024
Department of Neurology, University of Cologne, Medical Faculty, Cologne, Germany.
Background: Age represents the predominant risk factor for Alzheimer's disease (AD) dementia. Nevertheless, not every elderly individual undergoes age-related processes that inevitably lead to dementia. The aging process is characterized by cellular senescence, manifesting as morphological changes and the secretion of immune signaling mediators linked to systemic low-grade inflammation.
View Article and Find Full Text PDFStroke
January 2025
Department of Neurology, New York University Grossman School of Medicine, NY. (C.C., H.A., A.K., S.M.K.).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!